로딩 중…
StockDiggingStockDigging

4D Molecular Therapeutics, Inc.

FDMT· NASDAQ
$9.66+2.55%
2026-06-18

Price Chart

4D Molecular Therapeutics, Inc.+136.19%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$505M
Revenue$88M
Net Income$-161M
Total Assets$513M
Net Assets$452M
Value
P/B1.12x
P/S5.72x
FCF Yield-25.75%
Profitability
ROE-35.61%
ROA-31.37%
Op. Margin-203.47%
Revenue Growth21664.29%
Financial Health
Debt Ratio13.52%
Total Debt$21M
FCF$-130M
Cash$72M
Current Ratio9.34x
Performance
1Y Return136.19%
1M Return15.00%
From 52W High-21.72%
1Y MDD-41.40%
Trading
Volume487,136 shares
Trading Value$5M
Per Share
EPS$-2.42
BPS$8.73